Events and Presentations Immunic, Inc. Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing MS Print PageEmail PageRSS Feed Tuesday, October 22, 2024 8:00am EDT Download Presentation 836 KB Listen to the Webcast
